Medical devices including metallic film and at least one filament

Information

  • Patent Grant
  • 8864815
  • Patent Number
    8,864,815
  • Date Filed
    Tuesday, February 22, 2011
    13 years ago
  • Date Issued
    Tuesday, October 21, 2014
    10 years ago
Abstract
Medical devices, such as endoprostheses, and methods of making the devices are disclosed. The medical device can include a composite cover formed of a deposited metallic film. The cover may include one or more filaments, e.g., wires, which cooperate with the film to provide desirable mechanical properties. The wires may be integrated with the film by depositing the film over the wires.
Description
FIELD OF THE INVENTION

The invention relates to medical devices, such as endoprostheses, and methods of making the devices.


BACKGROUND

The body includes various passageways such as arteries, other blood vessels, and other body lumens. These passageways sometimes become occluded or weakened. For example, the passageways can be occluded by a tumor, restricted by plaque, or weakened by an aneurysm. When this occurs, the passageway can be reopened or reinforced, or even replaced, with a medical endoprosthesis. An endoprosthesis is typically a tubular member that is placed in a lumen in the body. Endoprostheses can be delivered inside the body by a catheter that supports the endoprosthesis in a compacted or reduced-size form as the endoprosthesis is transported to a desired site. Upon reaching the site, the endoprosthesis is expanded, for example, so that it can contact the walls of the lumen.


The expansion mechanism may include forcing the endoprosthesis to expand radially. For example, the expansion mechanism can include the catheter carrying a balloon, which carries a balloon-expandable endoprosthesis. The balloon can be inflated to deform and to fix the expanded endoprosthesis at a predetermined position in contact with the lumen wall. The balloon can then be deflated, and the catheter withdrawn.


In another delivery technique, the endoprosthesis is formed of an elastic material that can be reversibly compacted and expanded, e.g., elastically or through a material phase transition. During introduction into the body, the endoprosthesis is restrained in a radially compacted condition. Upon reaching the desired implantation site, the restraint is removed, for example, by retracting a restraining device such as an outer sheath, enabling the endoprosthesis to self-expand by its own internal elastic restoring force.


SUMMARY OF THE INVENTION

The invention relates to medical devices, such as endoprostheses, and methods of making the devices. Exemplary endoprostheses include stents, covered stents, and stent-grafts.


In some embodiments, an endoprosthesis includes a deposited metallic film defining first and second opposed surfaces and a thickness of less than about 50 μm therebetween and at least one metal filament. The at least one filament defines a length. At least a portion of the filament along its length is embedded within the deposited metallic film between its first and second surfaces.


The deposited metallic film may include deposited titanium and nickel, e.g., an alloy including nickel and titanium.


The deposited film may have a substantially tubular shape defining a longitudinal axis. The at least one filament may extend, e.g., linearly or helically, generally along the longitudinal axis.


The tubular shape of the film may define a length along the longitudinal axis and the length of the filament may be at least about 30% of the length of the tubular shape of the film.


The endoprosthesis may include a plurality of filaments each defining a length. At least a portion of each wire along its length may be embedded within the metallic film between the first and second surfaces. Each filament may extend generally along the longitudinal axis. The length of each filament may be at least 30% of the length of the tubular shape of the film.


At least 75% of the filament along its length may be embedded within the metallic film between the first and second surfaces of the metallic film.


The filament, along its length, may include a plurality of embedded portions and at least one non-embedded portion. Each embedded portion may be embedded within the metallic film between the first and second surfaces of the metallic film. Adjacent embedded portions may be spaced apart by a non-embedded portion of the filament.


The substantially tubular shape may define a circumference. The at least one filament may extend at least partially about the circumference.


The at least one filament may be an alloy comprising nickel and titanium.


The metallic film and the at least one filament may each have a respective tensile strength, with the tensile strength of the filament being greater than the tensile strength of the metallic film. The metallic film and the at least one filament may each have a respective, different shape set configuration.


The endoprosthesis may include a stent body. The stent body and the deposited film may be generally concentric.


In some embodiments, an endoprosthesis includes a cover including at least one deposited metallic film. The cover defines first and second opposed metallic film edges. The first and second opposed metallic film edges each define a channel. At least one filament may extend along the channel of each opposed metallic film edge.


The deposited metallic film may include deposited nickel and titanium, e.g., an alloy including nickel and titanium.


The cover may have a substantially tubular shape defining a longitudinal axis. The at least one filament may extend generally parallel to the longitudinal axis. The tubular shape may define a length along the longitudinal axis. The length of the filament may be at least about 30% of the length of the tubular shape.


The first and second opposed edges may each define at least one offset tab. The channel of each opposed edge may be formed by the offset tab.


The first and second opposed edges may each define a plurality of channels. Each channel may be formed by a respective offset tab. The filament may extend through at least some of the channels of each opposed edge.


The endoprosthesis may include a stent body. At least a portion of the at least one filament and at least a portion of the stent body may be secured together.


The filament may define a longitudinal axis. An engagement between at least one of the channels and the filament may restrict movement of the filament along its longitudinal axis with respect to the at least one of the channels. The filament may have freedom of movement along its length with respect to at least one of the channels.


The first and second opposed edges may be a first pair of opposed edges and metallic film of the cover may define a plurality of pairs of first and second opposed edges. Each edge of each pair may define at least one channel. A respective filament may extend through the channel of each opposed edge of each pair. Each pair of opposed edges may extend generally along the longitudinal axis. Each filament may have a length at least about 30% of the length of the tubular shape. The first and second edges of each pair of opposed edges may have at least some relative freedom of movement with respect to a circumference of the cover.


In one aspect, the invention features an endoprosthesis including a metallic film, e.g., a vapor deposited film, including nickel, titanium, and chromium. A ratio of a weight of chromium of the metallic film to a combined weight of nickel, titanium, and chromium of the metallic film is at least 0.001 and can be less than 0.0075.


Other aspects, features, and advantages of the invention will be apparent from the description of the preferred embodiments thereof and from the claims.





BRIEF DESCRIPTION OF THE FIGURES


FIG. 1 is a side view of an endoprosthesis in a radially expanded state as deployed within a body passage adjacent an aneurysm.



FIG. 2
a is a side view of a distal portion of a deployment device prior to radial expansion of the endoprosthesis.



FIG. 2
b is a side view of the distal portion of the deployment device subsequent to radial expansion of the endoprosthesis adjacent the aneurysm.



FIG. 3
a is a perspective view of an endoprosthesis.



FIG. 3
b is a cross-sectional view of the endoprosthesis of FIG. 3a.



FIG. 4 is a top view of a cover of the endoprosthesis of FIG. 3a. The cover is shown in two-dimensions and separate from the endoprosthesis.



FIG. 5
a is a cross-sectional end view of the cover of FIG. 4. Tabs of the cover have been formed into channels.



FIG. 5
b is the cover of FIG. 5a. The cover has been formed into a generally tubular shape.



FIG. 6 is a cover suitable for an endoprosthesis. The cover includes tabs forming channels, which are located within a circumference of the cover.



FIG. 7 is an endoprosthesis having a cover formed of two cover portions.



FIG. 8 is a cover having channels formed via metallic film deposition.



FIG. 9 is a cross-sectional view of an endoprosthesis including the cover of FIG. 8.



FIG. 10
a shows an endoprosthesis having a plurality of integral, longitudinally extending filaments.



FIG. 10
b is a cross-sectional view of the endoprosthesis of FIG. 10a.



FIG. 11 is a cover suitable for an endoprosthesis. The cover has a plurality of longitudinally extending filaments each having a plurality of embedded integral portions and a plurality of exposed portions.





DETAILED DESCRIPTION

Referring to FIG. 1, an endoprosthesis 100 is deployed within a body passage, e.g., within a vessel weakened by an aneurysm, e.g., an aneurysm 25 of a vessel 26 of a human brain. Endoprosthesis 100 includes a framework, e.g., a stent body 52, covered by a tubular member or cover 54. The stent body provides a relatively rigid framework that secures the endoprosthesis at the treatment site. The framework defines relatively large openings or fenestrations that contribute to the mechanical properties of the stent. The cover 54 is relatively thin and flexible and includes smaller fenestrations that contribute to the mechanical properties of the cover and occlude the fenestrations of the stent.


The endoprosthesis 100 modifies an amount or velocity of blood passing between vessel 26 and aneurysm 25. For example, prosthesis 100 can be deployed to reduce or block blood flow between vessel 26 and aneurysm 25. The endoprosthesis can also reduce blood flow from a feeder vessel 27. If so deployed, prosthesis 100 may sufficiently reduce blood flow to allow clotting or other healing processes to take place within aneurysm 25 and/or opening 29. Tubular member 54 can provide a greater attenuation of the blood flow into the aneurysm 25 than stent body 52 alone. Endoprosthesis 100, however, can allow some flow to pass between vessel 26 and aneurysm 25 even while providing some reduction in the rate and/or volume of flow. Prosthesis 100 can also (or alternatively) allow blood to pass between vessel 26 containing the prosthesis and adjacent vessels, e.g., feeder vessel 27, while still providing reduced flow with respect to the aneurysm.


Referring to FIGS. 2a and 2b, endoprosthesis 100 is deployed to aneurysm 25 using a deployment device 30, such as a catheter that can be threaded through a tortuous pathway. The device 30 includes a retractable outer sheath 31 and an inner catheter 32. Device 30 is introduced over a guide wire 37 extending along the interior 28 of vessel 26. During introduction, the endoprosthesis 100 is radially compacted between outer sheath 31 and inner catheter 32 adjacent a distal opening 40 of the outer sheath.


Referring particularly to FIG. 2b, the outer sheath 31 is retracted upon reaching the desired deployment site, e.g., aneurysm 25. In some embodiments, endoprosthesis 100 self-expands by its own internal elastic restoring force when the radially restraining outer sheath is retracted. Alternatively, or in combination with self-expansion, deployment of prosthesis 100 may include use of a balloon or other device to radially expand prosthesis 100 within vessel 26. After deploying the endoprosthesis, the inner catheter 32 and guide wire 37 are withdrawn from vessel 26. Suitable delivery systems include the Neuroform, Neuroform2, and Wingspan Stent System available from Boston Scientific Target Therapeutics, Fremont, Calif. In embodiments, the outer sheath and/or inner catheter includes a reinforcing member to respectively resist elongation or compression as the outer sheath is withdrawn. Such reinforcing members include polymer shafts, braids, and coil structures.


Upon expansion, endoprosthesis 100 assumes a shape and radial extent generally coextensive with an inner surface of the vessel 26, e.g., a tubular shape centered about a longitudinal axis a1 of the prosthesis (FIG. 1). Depending upon the application, prosthesis 100 can have a diameter d of between, for example, 1 mm to 46 mm. In certain embodiments, a prosthesis for deployment within a vessel at an aneurysm can have an expanded diameter d of from about 2 mm to about 6 mm, e.g., about 2.5 mm to about 4.5 mm. Depending upon the application, prosthesis 100 can have a length along axis a1 of at least 5 mm, at least 10 mm, e.g., at least about 30 mm. An exemplary embodiment has an expanded diameter of about 3.5 mm and a length of about 15 mm. In embodiments, the stent body has a closed cell framework, an open cell framework, a helical framework, a braided framework, or combination thereof.


The cover can be fixed to the stent by, e.g. fasteners. Attachment techniques include brazing, welding or attachment with a filament, rivets or grommets, or crimping, or adhesive. In some embodiments, the tubular member differs from a fabric at least in that the tubular member lacks fibers that can be pushed apart to receive a filament as by sewing a fabric. Accordingly, the fenestrations can be formed prior to the process of passing the filament through the tubular member. Fenestrations that receive the filaments can be formed by, e.g., etching, laser cutting, or a photolithographic process. Attachment techniques are described in U.S. Ser. No. 11/025,866, titled MEDICAL DEVICES INCLUDING METALLIC FILMS AND METHODS FOR MAKING SAME, filed contemporaneously herewith, which application is incorporated herein by reference.


The cover is formed of a thin film that exhibits advantageous properties such as strength, toughness, and flexibility by selection of the composition of the film, processing techniques, and mechanical configuration. For example, in particular embodiments, the film is a vapor-deposited material composed of a nickel-titanium alloy having a strength additive, e.g. chromium. The film has a thickness of about 50 μm or less, e.g. about 4-35 μm, and includes fine fenestrations, which facilitate collapsing the film to small diameter for delivery into the body and expansion at the treatment site, while impeding blood access to the aneurysm. In particular embodiments, the film is processed to modify dislocations, which contribute to strength and toughness of the thin film.


Deposited materials are formed by depositing film constituents from a suspended state, e.g. in a vapor or a vacuum onto a surface. In embodiments, the constituents are suspended, e.g. by bombarding, heating or sputtering a bulk target. The suspended constituents deposit on a substrate to form the film. Deposited films can exhibit highly uniform thickness and microstructure in very thin films, e.g. about 50 μm or less, e.g. 4-35 μm. Deposition techniques include sputter deposition, pulsed laser deposition, ion beam deposition and plasma deposition. Suitable deposition processes are described in Busch et al. U.S. Pat. No. 5,061,914, Bose et al. U.S. Pat. No. 6,605,111, Johnston U.S. Pat. No. 6,533,905, and Gupta et al. U.S. 2004/0014253, the entire contents of all of which are hereby incorporated by reference.


In particular embodiments, the deposited film is an alloy that includes nickel and titanium, and a strength additive or additives, which modify a mechanical property, e.g., a hardness or elasticity, of the film. In particular embodiments, the film is a tertiary alloy that has substantially no other components besides nickel, titanium, and additive present in an amount greater than 1%, 0.5% or 0.2% or less than 20%, 10%, or 5% by weight of the film. The film may consist essentially of nickel, titanium, and chromium. In embodiments, the deposited film includes between 54 and 57 weight percent nickel with the balance composed essentially of titanium and chromium. In some embodiments, a ratio of a weight of chromium of the film to a combined weight of nickel, titanium, and chromium of the film is at least 0.001, at least 0.002 e.g., at least 0.0025. The ratio of the weight of chromium of the film to the combined weight of chromium, nickel, and titanium of the film can be 0.02 or less, 0.01 or less, e.g., 0.0075 or less. The ratio of the weight of chromium to the combined weight of chromium, nickel, and titanium of the film can be about 0.0025. In embodiments, the alloy exhibits superelastic or pseudo-elastic properties. Superelastic or pseudo-elastic metal alloy, as described, for example, in Schetsky, L. McDonald, “Shape Memory Alloys,” Encyclopedia of Chemical Technology (3rd ed.), John Wiley & Sons, 1982, vol. 20. pp. 726-736; and commonly assigned U.S. Ser. No. 10/346,487, filed Jan. 17, 2003.


A metallic film can be combined with one or more filaments in an endoprosthesis cover. Because the filaments and film may have very different mechanical properties, e.g., elongation before break and tensile strengths, the filaments and film cooperate to lend the cover desirable mechanical properties, e.g., toughness along the circumferential, radial, and/or longitudinal dimensions. In embodiments, a filament secures portions of a film relative to other portions of the film such as to maintain the three-dimensional shape of the cover and/or to secure the film with respect to a stent body.


Referring to FIGS. 3a, 3b, and 4, an endoprosthesis 150 includes a cover 154 encircling a stent body 152. First and second edges 157 and 159 of cover 152 define a plurality of offset tabs 156i (FIG. 4). When formed as a cover, each tab defines a respective channel 158i (FIG. 3a). Different channels 158i are coaxial with one another parallel to a length 1 of cover 152. A filament 160 seen in FIG. 3b extends within the coaxial channels along the length 1 and prevents cover 154 from unrolling by securing offset tabs 156i relative to one another.


Filament 160 can include, e.g., a suture, a polymer, a textile, or a metal, e.g., a metal wire formed of gold, platinum, stainless steel, or a shape memory metal, e.g., nitinol. A filament can include a combination of such materials, e.g., a composite. The filament can be braided and need not have a circular configuration, e.g., the filament can be ribbon shaped. The filament typically has a thickness or radial dimension of less than a thickness of the film. In embodiments, the member is a metal wire having a diameter of about 10 μm or less, about 8μ, e.g., about 5 μm or less.


The filament 160 can have a higher tensile strength than the film of the cover 154. In embodiments, a ratio of the tensile strength of the filament 160 to the tensile strength of the film is at least about 1.5, e.g., at least about 2. The ratio may be about 4 or less, e.g., about 3 or less. The filament may be a nitinol wire having a tensile strength of at least 200 ksi, at least 250 ksi, e.g., at least 300 ksi. An exemplary metallic film has a tensile strength of 150 ksi.


In some embodiments, the filament 160 includes a wire of shape memory metal that is shape set differently from a shape set of the metallic film. In some embodiments, one of the member 160 and metallic film is shape set at a configuration corresponding to the radially compressed state within a delivery device while the other of the member and film is shape set at a configuration corresponding to the radially expanded state within a body passage. A primary difference in the shape set between the member 160 and the cover may be in the shape set length, with one of the member and cover having a longer shape set length than the other.


An exemplary method of manufacturing cover 154 includes depositing a metallic film on a substrate. The cover can be provided with fenestrations 62, which are not shown in FIG. 3a. Tabs 156i can be formed by photolithography or machined, e.g., by laser cutting, from a larger deposited film. Referring to FIG. 5a, each tab 156i is turned about itself to form a respective channel 158i. Referring to FIG. 5b, if not deposited on a three-dimensional substrate, the film can be rolled, e.g., about a mandrel, to provide a three-dimensional shape.


Adjacent tabs 156i are relatively secured by filament 160. The filament 160 can be inserted along the common axis of channels 158i or inserted laterally through a terminal gap Δg of each tab. If present, the terminal gap of each tab can be closed after introducing member 160. Either before or after positioning filament 160 with respect to tabs 156i, film 154 can be disposed with respect to a stent body, e.g., about the stent body (FIG. 3b). The cover and stent body can be relatively secured with, e.g., one or more filaments 59, which pass through fenestrations of the cover and engage framework members 58 of the stent body. In embodiments, some or all of the tabs engage a portion of the stent body, e.g., a framework member 58, to secure the cover and stent body.


In some embodiments, filament 160 and some or all of tabs 156i have little or no relative freedom of movement. For example, each tab 156i may mechanically engage filament 160 via a tight fit between respective channel 158i and the member 160. An adhesive or other polymer may also or alternatively be used to enhance the engagement between the filament and the channels of the tabs.


In embodiments, filament 160 and some or all of channels 158i allow some relative freedom of movement, e.g., longitudinal or circumferential freedom of movement. During radial compression and expansion of an endoprosthesis, the cover 154 and filament 160 move relatively to accommodate different length changes without deforming the cover or endoprosthesis. Longitudinal freedom of movement may be provided by a filament not tightly engaged by the channels, e.g., by a filament having a diameter smaller than an inner diameter of the channels. Circumferential freedom of movement can be provided by circumferentially elongating the channels so that the cover edges 157,159 can move circumferentially relative to one another, e.g., toward and away from one another. Adjacent tabs 156i and 156i±1 may define gaps (not shown) to allow the cover edges some relative longitudinal freedom of movement. An elastic polymer may fill the channels to help retain the filament yet allow some relative movement.


Channels 158i are shown as extending coaxially the entire length of the cover. In some embodiments, channels 158i extend along only a portion of the cover length, e.g., ½ the length or less, ⅓ the length or less, or ¼ the length or less. The resulting “shorter” channel may be located anywhere along the length of the endoprosthesis, e.g., centrally or distally or proximally relative to an implanted prosthesis.


Channels 158i are shown as generally parallel with a longitudinal axis of the endoprosthesis 150. In embodiments, the channels 158i and filaments can have other configurations, e.g., circumferential, curved, or helical about the endoprosthesis.


Referring to FIG. 6, a cover 225 includes tabs 227i and channels 229i located within an external circumference of the cover. Accordingly, when relatively secured and placed concentrically with respect to a stent body, the cover forms a relatively smooth outer surface with little or no ridge-like protrusion resulting from the tabs 227i. Channels 229i may also be used to engage a framework member 58 of a stent body, which engagement can secure the cover and stent body.


Referring to FIG. 7, a cover 175 having first and second cover portions 177,179 encircles a stent body having framework members 58. Each cover portion defines first and second edges. First edges and second edges of cover portions 177,179 are secured to one another by first and second sets of offset tabs 181i,183i, which form respective channels 182i,184i. The channels of different tabs are coaxial aligned and extend along at least a portion of the length of the endoprosthesis. A filament 160 extends along the coaxial channels. Although only two cover portions are shown, an endoprosthesis can have even more cover portions, e.g., 3 or more, 4 or more, or 5 or more, which combine to form a generally tubular cover.


Cover portions 177,179 may have some freedom of movement relative to one another. For example, by allowing longitudinal or circumferential freedom of movement between different cover portions, an endoprosthesis can accommodate delivery or deployment within a tortuous body passage having small radius curves. Freedom of movement between the cover portions can be provided using, e.g., the techniques described for providing relative freedom of movement between a filament and cover.


Referring to FIGS. 8 and 9, an endoprosthesis cover 200 includes tabs having integral channels 208i formed by, e.g., three-dimensional deposition over a sacrificial medium. Each integral channel defines a complete circumference without a seam resulting from mechanical channel formation. An endoprosthesis 201 is formed by positioning the cover 200 about a stent body having framework members 58 and securing the tabs with a filament 160 (FIG. 9).


An exemplary method of manufacturing cover 200 includes depositing a first layer of metallic film on a substrate, whether two- or three-dimensional. A sacrificial medium, e.g., chromium, is photolithographically deposited over portions of the previously deposited film.


The sacrificial medium is formed of a material, e.g., chromium, that can be removed, e.g., by etching, from the metallic film without damage thereto. Additional material of the metallic film is deposited over the sacrificial medium to complete the film. Subsequently, the sacrificial medium is removed from the remaining film leaving behind the integral channels.


Referring to FIGS. 10a and 10b, a cover 300 (shown without a stent body) includes longitudinal channels 302 each formed by depositing metal about a filament 160. In this embodiment, the filament is typically a metal ribbon or wire, e.g., a metal wire of shape memory alloy. Depositing the metallic film about the wire secures the two together and ensures that the mechanical properties of each are communicated to the other without losses resulting from slippage. Although filaments 160 are shown as extending linearly along the longitudinal axis of the endoprosthesis, one or more of the filaments can have other longitudinally extending configurations, e.g., circumferential, curved, or helical. Filaments may intersect or cross one another. In other embodiments, some or all the wires do not intersect or cross another wire.


An exemplary method for forming cover 300 includes depositing a first layer of metallic film. Wires 160 are positioned adjacent the deposited film. Additional metal is deposited over the wires to integrate the wires and film. In an alternative method, wires 160 are positioned over a substrate. A first amount of metallic film is deposited over the wires and substrate. Subsequently, the first amount of film and substrate are separated and additional metal film is deposited to integrate the wires and film.


Referring to FIG. 11, a cover 325 includes a plurality of partially exposed filaments 160. Portions of the filaments 160 are embedded within a deposited metallic film of the cover and other portions of the filaments are left exposed. When formed about a stent body, the exposed portions of wire 160 can engage framework members of the stent body to secure the cover and stent body together. Another filament, e.g., a suture or wire, can be threaded through exposed portions of filaments 160 to secure the cover to a stent body or to retain the cover in a three-dimensional shape.


In some embodiments, a deposited thin film and including one or more filaments is useable as an endoprosthesis without a supporting stent. For example, an endoprosthesis without a supporting stent can include a deposited thin film including one or more at least partially embedded wires contributing to radial and/or longitudinal strength of the film.


In some embodiments, the filaments, whether embedded or not, extend beyond an end of the endoprosthesis. The extending filaments can be used to, e.g., re-sheath the endoprosthesis in order to change its position or withdraw it from a lumen, or to pull the endoprosthesis along a body lumen.


In the embodiment shown, an endoprosthesis has a generally tubular shape. In some embodiments, however, the endoprosthesis (or stent body 52 or tubular member 54 individually) has or includes other shapes such as conical, oblate, and branched. The endoprosthesis may have a closed end to form, e.g., a basket shape. Thin films, discussed above, composed of Ni—Ti-strength additive alloys and/or with modified microstructures, can be used in other applications. Examples include baskets, filters, catheters, guidewires, and medical balloons, such as an angioplasty balloon. Filaments of such endoprostheses may intersect or be woven to define a shape of the endoprosthesis.


Other examples of endoprostheses including a thin film as well as related systems and methods are described in U.S. provisional patent application No. 60/549,287, filed Mar. 2, 2004, which application is incorporated herein by reference.


An endoprosthesis may include a cover disposed externally to a framework as shown and/or internally of a framework. Endoprostheses having a cover including, e.g., a deposited thin film, disposed internally of a framework are described in U.S. patent application Ser. No. 11/025,464, titled MEDICAL DEVICES INCLUDING METALLIC FILMS AND METHODS FOR MAKING SAME, and filed concurrently herewith, which application is incorporated herein by reference.


An endoprosthesis may include features to enhance a flexibility of the endoprosthesis as described in U.S. patent application Ser. No. 11/025,158, titled MEDICAL DEVICES INCLUDING METALLIC FILMS AND METHODS FOR MAKING SAME, and filed concurrently herewith, which application is incorporated herein by reference.


The composition and/or fabrication method of a deposited thin film of an endoprosthesis may include features that enhance a strength or toughness of the film as described in U.S. patent application Ser. No. 11/025,860, titled MEDICAL DEVICES INCLUDING METALLIC FILMS AND METHODS FOR MAKING SAME, and filed concurrently herewith, which application is incorporated herein by reference.


An endoprosthesis may include a deposited thin film and a polymer as described in U.S. patent application Ser. No. 11/025,867, titled MEDICAL DEVICES INCLUDING METALLIC FILMS AND METHODS FOR MAKING SAME, and filed concurrently herewith, which application is incorporated herein by reference.


Methods for loading an endoprosthesis into a delivery device and systems for delivering an endoprosthesis to a treatment site are described in U.S. patent application Ser. No. 11/025,660, titled MEDICAL DEVICES INCLUDING METALLIC FILMS AND METHODS FOR LOADING AND DEPLOYING SAME, which application is incorporated herein by reference.


All publications, references, applications, and patents referred to herein are incorporated by reference in their entirety.


Other embodiments are within the claims.

Claims
  • 1. An endoprosthesis, comprising: a metallic film defining first and second opposed surfaces and a thickness of less than about 50 μm therebetween; and at least one filament, the at least one filament defining a length, at least two portions of the filament along its length being embedded within the metallic film between the first and second surfaces, the two portions being separated by a non-embedded portion of the filament.
  • 2. The endoprosthesis of claim 1, wherein the metallic film comprises titanium and nickel.
  • 3. The endoprosthesis of claim 1, wherein the metallic film has a substantially tubular shape defining a longitudinal axis and the at least one filament extends generally along the longitudinal axis.
  • 4. The endoprosthesis of claim 3, wherein the tubular shape of the metallic film defines a length along the longitudinal axis and the length of the at least one filament is at least about 30% of the length of the tubular shape of the metallic film.
  • 5. The endoprosthesis of claim 4, comprising a plurality of filaments each defining a length, at least a portion of each filament along its length being embedded within a metal alloy between the first and second surfaces of the metallic film, each filament extending generally along the longitudinal axis of the metallic film, the length of each filament being at least 30% of the length of the tubular shape of the metallic film.
  • 6. The endoprosthesis of claim 4, wherein at least 75% of the filament along its length is embedded within a metal alloy between the first and second surfaces of the metallic film.
  • 7. The endoprosthesis of claim 4, wherein the at least one filament comprises an alloy comprising nickel and titanium.
  • 8. The endoprosthesis of claim 7, wherein the metallic film and the at least one filament each have a respective tensile strength, the tensile strength of the at least one filament being greater than the tensile strength of the metallic film.
  • 9. An endoprosthesis, comprising: a metallic film defining first and second opposed metallic film edges, the first and second opposed metallic film edges each defining a channel; andat least one filament, the at least one filament extending through the channel of each opposed metallic film edge.
  • 10. The endoprosthesis of claim 9, wherein the metallic film comprises nickel and titanium.
  • 11. The endoprosthesis of claim 9, wherein the metallic film has a substantially tubular shape defining a longitudinal axis and the at least one filament extends generally parallel to the longitudinal axis.
  • 12. The endoprosthesis of claim 11, wherein the tubular shape defines a length along the longitudinal axis and the length of the at least one filament is at least about 30% of the length of the tubular shape.
  • 13. The endoprosthesis of claim 11, wherein the first and second opposed edges each define at least one offset tab, the channel of each opposed edge being formed by the offset tab.
  • 14. The endoprosthesis of claim 13, wherein the first and second opposed edges each define a plurality of channels, each channel being formed by a respective offset tab, the at least one filament extending through at least some of the channels of each opposed edge.
  • 15. The endoprosthesis of claim 11, wherein the endoprosthesis comprises a stent body, at least a portion of the at least one filament and at least a portion of the stent body being secured together.
  • 16. The endoprosthesis of claim 11, wherein the at least one filament defines a longitudinal axis, an engagement between at least one of the channels and the at least one filament restricting movement of the at least one filament along its longitudinal axis with respect to the at least one of the channels.
  • 17. The endoprosthesis of claim 11, wherein the first and second opposed edges are a first pair of opposed edges and the metallic film defines a plurality of pairs of first and second opposed edges, each edge of each pair defining at least one channel, a respective filament extending through the channel of each opposed edge of each pair.
  • 18. The endoprosthesis of claim 17, wherein each pair of opposed edges extends generally along the longitudinal axis of the metallic film and the at least one filament has a length at least about 30% of the length of the tubular shape.
  • 19. The endoprosthesis of claim 18, wherein the first and second edges of each pair of opposed edges have at least some relative freedom of movement with respect to a circumference of the metallic film.
  • 20. A method of manufacturing an endoprosthesis, comprising: embedding at least two portions of a filament along a length of the filament within a metallic film, the two portions being separated by a non-embedded portion of the filament,wherein the metallic film defines first and second opposed surfaces and a thickness of less than about 50 μm there between, and the at least a portion of the filament is embedded within the metallic film between the first and second surfaces.
  • 21. A method of manufacturing an endoprosthesis, comprising: forming a metallic film defining first and second opposed metallic film edges, the first and second opposed metallic film edges each defining a channel; andextending a filament through the channel of each opposed metallic film edge.
CROSS REFERENCE TO RELATED APPLICATION

This application is a continuation of U.S. patent application Ser. No. 11/025,684, filed Dec. 29, 2004. The disclosure of the prior application is hereby incorporated by reference in its entirety.

US Referenced Citations (208)
Number Name Date Kind
4793348 Palmaz Dec 1988 A
4864824 Gabriel et al. Sep 1989 A
5035706 Giantureo et al. Jul 1991 A
5061914 Busch et al. Oct 1991 A
5085535 Solberg et al. Feb 1992 A
5119555 Johnson Jun 1992 A
5245738 Johnson Sep 1993 A
5302261 LeRoy et al. Apr 1994 A
5306294 Winston et al. Apr 1994 A
5325880 Johnson et al. Jul 1994 A
5382261 Palmaz Jan 1995 A
5405378 Strecker et al. Apr 1995 A
5441515 Khosravi et al. Aug 1995 A
5518680 Cima et al. May 1996 A
5554182 Dinh et al. Sep 1996 A
5556413 Lam Sep 1996 A
5607466 Imbert et al. Mar 1997 A
5619177 Johnson et al. Apr 1997 A
5656036 Palmaz Aug 1997 A
5667523 Bynon et al. Sep 1997 A
5674242 Phan et al. Oct 1997 A
5676697 McDonald Oct 1997 A
5728150 McDonald et al. Mar 1998 A
5755734 Richter et al. May 1998 A
5800517 Anderson et al. Sep 1998 A
5817102 Johnson et al. Oct 1998 A
5824042 Lombardi et al. Oct 1998 A
5824049 Ragheb et al. Oct 1998 A
5824054 Khosravi et al. Oct 1998 A
RE35988 Winston et al. Dec 1998 E
5843158 Lenker et al. Dec 1998 A
5843164 Frantzen et al. Dec 1998 A
5843289 Lee et al. Dec 1998 A
5849206 Amon et al. Dec 1998 A
5860998 Robinson et al. Jan 1999 A
5865723 Love Feb 1999 A
5882444 Flomenblit et al. Mar 1999 A
5888734 Cremer et al. Mar 1999 A
5897911 Loeffler Apr 1999 A
5903099 Johnson et al. May 1999 A
5938697 Killion et al. Aug 1999 A
5941249 Maynard Aug 1999 A
5957929 Brenneman Sep 1999 A
5984963 Ryan et al. Nov 1999 A
6007573 Wallace et al. Dec 1999 A
6015431 Thornton et al. Jan 2000 A
6015433 Roth Jan 2000 A
6017977 Evans et al. Jan 2000 A
6036725 Avellanet Mar 2000 A
6043451 Julien et al. Mar 2000 A
6048622 Hagood et al. Apr 2000 A
6059766 Greff May 2000 A
6077298 Tu et al. Jun 2000 A
6096175 Roth Aug 2000 A
6099561 Alt Aug 2000 A
6107004 Donadio, III Aug 2000 A
6120535 McDonald et al. Sep 2000 A
6132460 Thompson Oct 2000 A
6133547 Maynard Oct 2000 A
6139564 Teoh Oct 2000 A
6143022 Shull et al. Nov 2000 A
6159239 Greenhalgh Dec 2000 A
6174330 Stinson Jan 2001 B1
6190404 Palmaz et al. Feb 2001 B1
6206911 Milo Mar 2001 B1
6224627 Armstrong et al. May 2001 B1
6224630 Bao et al. May 2001 B1
6245104 Alt Jun 2001 B1
6254628 Wallace et al. Jul 2001 B1
6258117 Camrud et al. Jul 2001 B1
6290720 Khosravi et al. Sep 2001 B1
6303100 Ricci et al. Oct 2001 B1
6315788 Roby Nov 2001 B1
6315794 Richter Nov 2001 B1
6355055 Waksman et al. Mar 2002 B1
6379383 Palmaz et al. Apr 2002 B1
6398803 Layne et al. Jun 2002 B1
6406487 Brenneman Jun 2002 B2
6406490 Roth Jun 2002 B1
6409749 Maynard Jun 2002 B1
6428569 Brown Aug 2002 B1
6447478 Maynard Sep 2002 B1
6454738 Tran et al. Sep 2002 B1
6458152 Khosravi et al. Oct 2002 B1
6458153 Bailey et al. Oct 2002 B1
6471980 Sirhan et al. Oct 2002 B2
6485510 Camrud et al. Nov 2002 B1
6506211 Skubitz et al. Jan 2003 B1
6520984 Garrison et al. Feb 2003 B1
6527919 Roth Mar 2003 B1
6533905 Johnson et al. Mar 2003 B2
6537310 Palmaz et al. Mar 2003 B1
6605111 Bose et al. Aug 2003 B2
6614570 Johnson et al. Sep 2003 B2
6618921 Thornton Sep 2003 B1
6620192 Jalisi Sep 2003 B1
6620634 Johnson et al. Sep 2003 B2
6624730 Johnson et al. Sep 2003 B2
6629993 Voinov Oct 2003 B2
6632240 Khosravi et al. Oct 2003 B2
6638301 Chandrasekaran et al. Oct 2003 B1
6666882 Bose et al. Dec 2003 B1
6669719 Wallace et al. Dec 2003 B2
6669721 Bose et al. Dec 2003 B1
6669795 Johnson et al. Dec 2003 B2
6673102 Vonesh et al. Jan 2004 B1
6676987 Zhong et al. Jan 2004 B2
6695865 Boyle et al. Feb 2004 B2
6699278 Fischell et al. Mar 2004 B2
6699279 Stevens et al. Mar 2004 B2
6746478 Jayaraman Jun 2004 B2
6752826 Holloway et al. Jun 2004 B2
6767418 Zhang et al. Jul 2004 B1
6776795 Pelton Aug 2004 B2
6820676 Palmaz et al. Nov 2004 B2
6849085 Marton Feb 2005 B2
6936066 Palmaz et al. Aug 2005 B2
6953560 Castro et al. Oct 2005 B1
7105018 Yip et al. Sep 2006 B1
7279175 Chen et al. Oct 2007 B2
7410497 Hastings et al. Aug 2008 B2
7632303 Stalker et al. Dec 2009 B1
7901447 Molaei et al. Mar 2011 B2
7947071 Schmid et al. May 2011 B2
20010001834 Palmaz et al. May 2001 A1
20010032013 Marton Oct 2001 A1
20010039449 Johnson et al. Nov 2001 A1
20010044647 Pinchuk et al. Nov 2001 A1
20020007958 Rivelli et al. Jan 2002 A1
20020017503 Banas et al. Feb 2002 A1
20020019662 Brauckman et al. Feb 2002 A1
20020035774 Austin Mar 2002 A1
20020042645 Shannon Apr 2002 A1
20020046783 Johnson et al. Apr 2002 A1
20020142119 Seward et al. Oct 2002 A1
20020151965 Roth Oct 2002 A1
20020161342 Rivelli, Jr. et al. Oct 2002 A1
20020162605 Horton et al. Nov 2002 A1
20020165576 Boyle et al. Nov 2002 A1
20020165600 Banas et al. Nov 2002 A1
20020173809 Fleischman et al. Nov 2002 A1
20020187288 Lim et al. Dec 2002 A1
20020193869 Dang Dec 2002 A1
20020195579 Johnson Dec 2002 A1
20020198584 Unsworth et al. Dec 2002 A1
20030002994 Johnson et al. Jan 2003 A1
20030004567 Boyle et al. Jan 2003 A1
20030018354 Roth et al. Jan 2003 A1
20030023303 Palmaz et al. Jan 2003 A1
20030040791 Oktay Feb 2003 A1
20030050691 Shifrin et al. Mar 2003 A1
20030059640 Marton et al. Mar 2003 A1
20030060782 Bose et al. Mar 2003 A1
20030074049 Hoganson et al. Apr 2003 A1
20030078649 Camrud et al. Apr 2003 A1
20030083731 Kramer et al. May 2003 A1
20030127318 Johnson et al. Jul 2003 A1
20030130718 Palmas et al. Jul 2003 A1
20030130721 Martin et al. Jul 2003 A1
20030139797 Johnson et al. Jul 2003 A1
20030153971 Chandrasekaran Aug 2003 A1
20030159920 Roth Aug 2003 A1
20030185895 Lanphere et al. Oct 2003 A1
20030187495 Cully et al. Oct 2003 A1
20030212430 Bose et al. Nov 2003 A1
20040006381 Sequin et al. Jan 2004 A1
20040014253 Gupta et al. Jan 2004 A1
20040030377 Dubson et al. Feb 2004 A1
20040034408 Majercak et al. Feb 2004 A1
20040054399 Roth et al. Mar 2004 A1
20040054406 Dubson et al. Mar 2004 A1
20040059410 Cox Mar 2004 A1
20040098095 Burnside et al. May 2004 A1
20040107004 Levine et al. Jun 2004 A1
20040143317 Stinson et al. Jul 2004 A1
20040199239 Austin et al. Oct 2004 A1
20040225350 Shanley Nov 2004 A1
20040254520 Porteous et al. Dec 2004 A1
20050004653 Gerberding et al. Jan 2005 A1
20050010275 Sahatjian et al. Jan 2005 A1
20050033399 Richter Feb 2005 A1
20050165468 Marton Jul 2005 A1
20050165469 Hogendijk Jul 2005 A1
20050197687 Molaei et al. Sep 2005 A1
20050197689 Molaei et al. Sep 2005 A1
20050197690 Molaei et al. Sep 2005 A1
20060069428 Feller Mar 2006 A1
20060100659 Dinh et al. May 2006 A1
20060115514 Gengrinovitch Jun 2006 A1
20060122691 Richter Jun 2006 A1
20060142838 Molaei et al. Jun 2006 A1
20060142842 Molaei et al. Jun 2006 A1
20060142845 Molaei et al. Jun 2006 A1
20060142851 Molaei et al. Jun 2006 A1
20060147492 Hunter et al. Jul 2006 A1
20060184231 Rucker Aug 2006 A1
20060259131 Molaei et al. Nov 2006 A1
20060271158 Olson Nov 2006 A1
20070016283 Greenhalgh et al. Jan 2007 A1
20070073385 Schaeffer et al. Mar 2007 A1
20070112411 Obermiller et al. May 2007 A1
20070250156 Palmaz Oct 2007 A1
20080027388 Banas et al. Jan 2008 A1
20080221665 Peckham et al. Sep 2008 A1
20090132022 Banas May 2009 A1
20090187240 Clerc et al. Jul 2009 A1
20100030320 Feller, III Feb 2010 A1
20110054590 Leopold et al. Mar 2011 A1
Foreign Referenced Citations (47)
Number Date Country
0 472 731 Aug 1991 EP
0 792 627 Sep 1997 EP
1 604 697 Dec 2005 EP
1 725 186 Nov 2006 EP
1 725 187 Nov 2006 EP
1 725 188 Nov 2006 EP
2 125 442 Mar 1984 GB
2003102849 Aug 2003 JP
2007502069 Sep 2007 JP
2007526098 Sep 2007 JP
2007526099 Sep 2007 JP
WO 9606814 Mar 1996 WO
WO 9853362 Nov 1998 WO
WO 9902092 Jan 1999 WO
WO 9960267 Dec 1999 WO
WO 9962432 Dec 1999 WO
WO 0062711 Oct 2000 WO
WO 0121097 Mar 2001 WO
WO 0153559 Jul 2001 WO
WO 0187371 Nov 2001 WO
WO 0189420 Nov 2001 WO
WO 0191823 Dec 2001 WO
WO 0195697 Dec 2001 WO
WO 0234163 May 2002 WO
WO 0238080 May 2002 WO
WO 0238086 May 2002 WO
WO 02060506 Aug 2002 WO
WO 03003943 Jan 2003 WO
WO 03011363 Feb 2003 WO
WO 03013337 Feb 2003 WO
WO 03015840 Feb 2003 WO
WO 03018100 Mar 2003 WO
WO 03075793 Sep 2003 WO
WO 03075799 Sep 2003 WO
WO 03099161 Dec 2003 WO
WO 2004002370 Jan 2004 WO
WO 2004008504 Jan 2004 WO
WO 2004028340 Apr 2004 WO
2005084583 Sep 2005 WO
2005084584 Sep 2005 WO
2005084585 Sep 2005 WO
2006125022 Apr 2006 WO
2006071215 Jul 2006 WO
2006071242 Jul 2006 WO
2006071243 Jul 2006 WO
2006071244 Jul 2006 WO
2006071245 Jul 2006 WO
Non-Patent Literature Citations (25)
Entry
0566WO1 ISR—PCT/US2005/007282 mailed Jul. 5, 2005, 15 pages.
0567WO1 ISR—PCT/US2005/006993 mailed Aug. 2, 2005, 21 pages.
0568WO1 ISR—PCT/US2005/007161 mailed Jul. 28, 2005, 45 pages.
0569WO1 ISR—PCT/US2005/007173 mailed Dec. 6, 2005, 19 pages.
0570WO1 ISR—PCT/US2005/007164 mailed Jul. 5, 2005, 13 pages.
0596WO1 ISR—PCT/US2005/007162 mailed Oct. 4, 2005, 16 pages.
0621WO1 ISR—PCT/US2005/006895 mailed Mar. 2, 2005, 16 pages.
0627WO1 ISR—PCT/US2006/019126 mailed Feb. 1, 2007, 16 pages.
Dieter, George, Mechanical Metallurgy, Singapore, McGraw-Hill Book Co., 10th Printing 1984, pp. 111-117, 142-145, and 234-237. TA405.D53.
Freiherr, Greg, “Shape-Memory Alloys Offer Untapped”, Medical Device & Diagnostic Industry Magazine, Mar. 1998, 5 pages [retrieved on Jun. 30, 2004].
Fu et al., “TiNi-based thin films in MEMS applications: a review”, Sensors and Actuators, Article in Press, Elsevier, Feb. 2004, 14 pages.
Gertner et al., “Drug Delivery from Electrochemically Deposited Thin Metal Films”, Electrochemical and Sold-State Letter, 6 (4) J4-J6, 2003.
Gertner et al., “Electrochemistry and Medical Devices: Friend or Foe?”, The Electrochemical Society Interface, Fall 2003, pp. 20-24.
Gupta et al., “Nitinol Thin Film Three-Dimensional Devices—Fabrication and Applications”, http://www.tinialloy.com/pdf/smst.pdf, Sep. 7, 2003 [retrieved Dec. 1, 2004].
He et al., “CO2 laser annealing of sputtering deposited NiTi shape memory thin films”, Journal of Micromechanics and Microengineering, May 20, 2004, pp. 950-956.
Kaczmarek, S. M., “Pulsed laser deposition—today and tomorrow”, STL'96, Proc. SPIE, vol. 3187, 1997, pp. 129-134.
Krebs et al., “Pulsed Laser Deposition (PLD)—a Versatile Thin Film Technique”, Advances in Solid State Physics 2003, 43, 505-517.
Nakayama et al., “Fabrication of micropored elastomeric film-covered stents and acute-phase performances”, Journal of Biomedical Mateirals Research Part A, vol. 64A, Issue 1, Sep. 30, 2002, pp. 52-61.
Neocera, Inc. Brochure—Pulsed Laser Deposition, www.neocera.com [retrieved Dec. 1, 2004].
Padhi et al., “Planarization of Copper Thin Films by Electropolishing in Phosphoric Acid for ULSI Application”, Journal of Electrochemical Society, vol. 150, 2003, pp. G10-G14.
Pelleiter et al., “Effect of high energy argon implantation into NiTi shape memory alloy”, Surface and Coatings Technology, 158-159, 2002, pp. 301-308.
Ren et al., “Carbon nitride materials synthesized by Ion-assisted pulsed laser deposition”, Riken Review No. 43, Jan. 2002, pp. 41-44.
Schetky et al., “Issues in the Further Development of Nitinol Properties and Processing for Medical Device Application”, Proceedings, ASM Materials & Processes for Medical Devices Conference, Anaheim, in press, 2003, 6 pages.
Shabalovskaya et al., “Comparative performances of Nitinol surfaces in protein adsorption and platelet adhesion—Preliminary results”, Institute for Physical Research and Technology, Ames Laboratory, Ames, IA University of Washington, Seattle WA Memry Corporation, Bethel CT, 2004, 10 pages.
Stoeckel et al., “A survey of stent designs”, Min Invas Ther & Allied Technol, 11(4), 2002, pp. 137-147.
Related Publications (1)
Number Date Country
20110144740 A1 Jun 2011 US
Continuations (1)
Number Date Country
Parent 11025684 Dec 2004 US
Child 13031923 US